Mohammed S. Abdel-Maksoud
Discovery of New Imidazo[2,1-b]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma Activity
Abdel-Maksoud, Mohammed S.; El-Gamal, Mohammed I.; Lee, Bong S.; Gamal El-Din, Mahmoud M.; Jeon, Hong R.; Kwon, Dow; Ammar, Usama M.; Mersal, Karim I.; Ali, Eslam M. H.; Lee, Kyung-Tae; Yoo, Kyung Ho; Han, Dong Keun; Lee, Jae Kyun; Kim, Garam; Choi, Hong Seok; Kwon, Young Jik; Lee, Kwan Hyi; Oh, Chang Hyun
Authors
Mohammed I. El-Gamal
Bong S. Lee
Mahmoud M. Gamal El-Din
Hong R. Jeon
Dow Kwon
Dr Usama Ammar U.Ammar@napier.ac.uk
Lecturer
Karim I. Mersal
Eslam M. H. Ali
Kyung-Tae Lee
Kyung Ho Yoo
Dong Keun Han
Jae Kyun Lee
Garam Kim
Hong Seok Choi
Young Jik Kwon
Kwan Hyi Lee
Chang Hyun Oh
Abstract
BRAF is an important component of MAPK cascade. Mutation of BRAF, in particular V600E, leads to hyperactivation of the MAPK pathway and uncontrolled cellular growth. Resistance to selective inhibitors of mutated BRAF is a major obstacle against treatment of many cancer types. In this work, a series of new (imidazo[2,1-b]thiazol-5-yl)pyrimidine derivatives possessing a terminal sulfonamide moiety were synthesized. Pan-RAF inhibitory effect of the new series was investigated, and structure−activity relationship is discussed. Antiproliferative activity of the target compounds was tested against the NCI-60 cell line panel. The most active compounds were further tested to obtain their IC 50 values against cancer cells. Compound 27c with terminal open chain sulfonamide and 38a with a cyclic sulfamide moiety showed the highest activity in enzymatic and cellular assay, and both compounds were able to inhibit phosphorylation of MEK and ERK. Compound 38a was selected for testing its in vivo activity against melanoma. Cellular and animal activities are reported.
Citation
Abdel-Maksoud, M. S., El-Gamal, M. I., Lee, B. S., Gamal El-Din, M. M., Jeon, H. R., Kwon, D., Ammar, U. M., Mersal, K. I., Ali, E. M. H., Lee, K.-T., Yoo, K. H., Han, D. K., Lee, J. K., Kim, G., Choi, H. S., Kwon, Y. J., Lee, K. H., & Oh, C. H. (2021). Discovery of New Imidazo[2,1-b]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma Activity. Journal of Medicinal Chemistry, 64(10), 6877-6901. https://doi.org/10.1021/acs.jmedchem.1c00230
Journal Article Type | Article |
---|---|
Online Publication Date | May 17, 2021 |
Publication Date | May 27, 2021 |
Deposit Date | Dec 11, 2022 |
Journal | Journal of Medicinal Chemistry |
Print ISSN | 0022-2623 |
Electronic ISSN | 1520-4804 |
Publisher | American Chemical Society |
Peer Reviewed | Peer Reviewed |
Volume | 64 |
Issue | 10 |
Pages | 6877-6901 |
DOI | https://doi.org/10.1021/acs.jmedchem.1c00230 |
Public URL | http://researchrepository.napier.ac.uk/Output/2973678 |
You might also like
Downloadable Citations
About Edinburgh Napier Research Repository
Administrator e-mail: repository@napier.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search